000 01613 a2200457 4500
005 20250517132151.0
264 0 _c20171026
008 201710s 0 0 eng d
022 _a1543-8392
024 7 _a10.1021/acs.molpharmaceut.6b00979
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMei, Ling
245 0 0 _aPolymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment.
_h[electronic resource]
260 _bMolecular pharmaceutics
_c02 2017
300 _a513-522 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Line, Tumor
650 0 4 _aDoxorubicin
_xchemistry
650 0 4 _aDrug Carriers
_xchemistry
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aHeparin, Low-Molecular-Weight
_xchemistry
650 0 4 _aHydrazones
_xchemistry
650 0 4 _aMale
650 0 4 _aMelanoma, Experimental
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aNeoplasm Metastasis
_xdrug therapy
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aP-Selectin
_xmetabolism
650 0 4 _aPolymers
_xchemistry
700 1 _aLiu, Yayuan
700 1 _aXia, Chunyu
700 1 _aZhou, Yubei
700 1 _aZhang, Zhirong
700 1 _aHe, Qin
773 0 _tMolecular pharmaceutics
_gvol. 14
_gno. 2
_gp. 513-522
856 4 0 _uhttps://doi.org/10.1021/acs.molpharmaceut.6b00979
_zAvailable from publisher's website
999 _c26734513
_d26734513